Tue. 14 May 2024, 8:47am ET
Benzinga
Earnings, Earnings Beats, News
Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.78) by 14.1 percent. This is a 50 percent increase over losses of $(1.34) per share from the same period last year. The company reported $380.57 thousand in sales this quarter.